Back
Kura Oncology Stock Price Chart

Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
25
KURA
Kura Oncology
Last Price:
$7.05
Seasonality Move:
10.3%
7 Day Trial
ALL ACCESS PASS
$
7

Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KURA is experiencing slight buying pressure.
Kura Oncology Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.42 | Sell |
20-day SMA: | 7.43 | Sell |
50-day SMA: | 7.79 | Sell |
200-day SMA: | 14.98 | Sell |
8-day EMA: | 7.34 | Sell |
20-day EMA: | 7.51 | Sell |
50-day EMA: | 8.2 | Sell |
200-day EMA: | 12.73 | Sell |
Kura Oncology Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.2 | Sell |
Relative Strength Index (14 RSI): | 41.17 | Sell |
Chaikin Money Flow: | 18688 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.21 - 7.91) | Sell |
Bollinger Bands (100): | (6.57 - 13.41) | Sell |
Kura Oncology Technical Analysis
Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Kura Oncology Stock
Is Kura Oncology Stock a Buy?
-
Kura Oncology share price is 7.14 while KURA 8-day simple moving average is 7.42, which is a Sell signal.
-
The stock price of KURA is 7.14 while Kura Oncology 20-day SMA is 7.43, which makes it a Sell.
-
Kura Oncology 50-day simple moving average is 7.79 while KURA share price is 7.14, making it a Sell technically.
-
KURA stock price is 7.14 and Kura Oncology 200-day simple moving average is 14.98, creating a Sell signal.
KURA Technical Analysis vs Fundamental Analysis
Sell
25
Kura Oncology (KURA)
is a Sell
Is Kura Oncology a Buy or a Sell?
-
Kura Oncology stock is rated a SellThe current Kura Oncology [KURA] share price is $7.14. The Score for KURA is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
Kura Oncology Stock Info
Market Cap:
576.6M
Price in USD:
7.14
Share Volume:
467.2K
Kura Oncology 52-Week Range
52-Week High:
23.48
52-Week Low:
6.79
Sell
25
Kura Oncology (KURA)
is a Sell
Kura Oncology Share Price Forecast
-
What is the Kura Oncology stock price today?The Kura Oncology stock price is 7.14 USD today.
-
Will KURA stock go up or go down?Kura Oncology> share price is forecast to RISE/FALL based on technical indicators
-
Is Kura Oncology overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Kura Oncology is overvalued.
Is Kura Oncology Stock a Buy?
-
Kura Oncology share price is 7.14 while KURA 8-day exponential moving average is 7.34, which is a Sell signal.
-
The stock price of KURA is 7.14 while Kura Oncology 20-day EMA is 7.51, which makes it a Sell.
-
Kura Oncology 50-day exponential moving average is 8.20 while KURA share price is 7.14, making it a Sell technically.
-
KURA stock price is 7.14 and Kura Oncology 200-day simple moving average is 12.73, creating a Sell signal.
Fundamental Analysis of Kura Oncology
Is Kura Oncology a good investment?
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.03 per share, an increase this year of $0.29 per share, and an increase next year of $0.07 per share.
Technical Analysis of Kura Oncology
Should I short Kura Oncology stock?
-
KURA Moving Average Covergence Divergence (MACD) indicator is -0.2, suggesting Kura Oncology is a Sell
-
Kura Oncology Relative Strength Index (RSI) is 41.17, which suggest Kura Oncology is oversold
-
The Bollinger Bands (25) for Kura Oncology is (7.21 - 7.91), which suggest Kura Oncology is a Sell
-
The Bollinger Bands (100) for Kura Oncology is (6.57 - 13.41), which suggest Kura Oncology is a Sell
* Kura Oncology stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.